Clinical Trials in Salt Lake City

Showing 9101-9120 of 12,670 trials

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

NCT00991120

The purpose of the Extension Phase of the COMPASS-HF study is to continue to observe the safety of the Chronicle® Implantable Hemodynamic Monitor (IHM) system and Chronicle ICD system and provide study doctors continued access to the heart pressure information recorded by the Chronicle devices which may be used to help manage heart failure. The Extension Phase of the COMPASS-HF study is limited to people who have already received the investigational system and are currently enrolled in a Chronicle IHM or ICD study.

Heart Failure

Medtronic Cardiac Rhythm and Heart Failure165 participantsStarted Oct 2009

Birmingham, Alabama, United States • Springfield, Illinois, United States • Fort Wayne, Indiana, United States +16 more locations

COMPLETEDPhase 3< 1 mile

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

NCT00279045

The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.

Diabetes Mellitus, Type 2

GlaxoSmithKline4,426 participantsStarted Jan 2000

Anniston, Alabama, United States • Birmingham, Alabama, United States • Mesa, Arizona, United States +487 more locations

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Find Trials by Condition in Salt Lake City

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Safety Escalating Repeat IV, in Stroke Patients

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

The Study of AZD8529 for Smoking Cessation in Female Smokers

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Predictors of Time to Viremia With an Analytic Treatment Interruption

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Inactivated Influenza Via Jet Injection

A Study of ABT-806 in Subjects With Advanced Solid Tumor Types